The prevalence and risk factors of medical adhesive-related skin injury in cancer patients with peripherally inserted central catheter: A systematic review and meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
8411 patients.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] MARSI is prevalent in cancer patients with PICC. Modifiable risk factors should guide prevention strategies, including careful adhesive selection and regular skin assessments to improve patient outcomes.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.6%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[BACKGROUND] Medical adhesive-related skin injury (MARSI) is a significant but underreported complication, particularly in cancer patients with peripherally inserted central catheters (PICC).
- 95% CI 18-26
- OR 2.593
- 연구 설계 systematic review
APA
Li J, Qian Q, et al. (2026). The prevalence and risk factors of medical adhesive-related skin injury in cancer patients with peripherally inserted central catheter: A systematic review and meta-analysis.. The journal of vascular access, 27(1), 80-89. https://doi.org/10.1177/11297298251319824
MLA
Li J, et al.. "The prevalence and risk factors of medical adhesive-related skin injury in cancer patients with peripherally inserted central catheter: A systematic review and meta-analysis.." The journal of vascular access, vol. 27, no. 1, 2026, pp. 80-89.
PMID
40269488 ↗
Abstract 한글 요약
[BACKGROUND] Medical adhesive-related skin injury (MARSI) is a significant but underreported complication, particularly in cancer patients with peripherally inserted central catheters (PICC). This systematic review and meta-analysis aimed to estimate the prevalence of MARSI and identify key risk factors in this patient population.
[METHODS] A systematic search of PubMed, Embase, the Cochrane Library, CNKI, Wanfang, and VIP was conducted to identify studies reporting MARSI prevalence and risk factors in cancer patients with PICC. Pooled prevalence estimates and odds ratios (ORs) for risk factors were calculated using a random-effects model. Heterogeneity was assessed using the statistic, and subgroup analyses were performed to explore potential sources of heterogeneity. Publication bias was assessed using funnel plots and Egger's test.
[RESULTS] A total of 20 studies met the inclusion criteria, encompassing 8411 patients. The pooled prevalence of MARSI was 22% (95% CI: 18-26), with substantial heterogeneity across studies ( = 96.3%). Subgroup analysis revealed that retrospective studies reported higher prevalence (25%) compared to prospective studies (16%). Key risk factors included advanced age (OR: 2.593, 95% CI: 1.322-5.089), higher BMI (OR: 2.927, 95% CI: 2.029-4.223), pre-existing skin conditions (OR: 2.487, 95% CI: 1.693-3.650), and the use of transparent film dressings (OR: 3.228, 95% CI: 2.086-5.001). Funnel plot and Egger's test showed no significant publication bias.
[CONCLUSIONS] MARSI is prevalent in cancer patients with PICC. Modifiable risk factors should guide prevention strategies, including careful adhesive selection and regular skin assessments to improve patient outcomes.
[METHODS] A systematic search of PubMed, Embase, the Cochrane Library, CNKI, Wanfang, and VIP was conducted to identify studies reporting MARSI prevalence and risk factors in cancer patients with PICC. Pooled prevalence estimates and odds ratios (ORs) for risk factors were calculated using a random-effects model. Heterogeneity was assessed using the statistic, and subgroup analyses were performed to explore potential sources of heterogeneity. Publication bias was assessed using funnel plots and Egger's test.
[RESULTS] A total of 20 studies met the inclusion criteria, encompassing 8411 patients. The pooled prevalence of MARSI was 22% (95% CI: 18-26), with substantial heterogeneity across studies ( = 96.3%). Subgroup analysis revealed that retrospective studies reported higher prevalence (25%) compared to prospective studies (16%). Key risk factors included advanced age (OR: 2.593, 95% CI: 1.322-5.089), higher BMI (OR: 2.927, 95% CI: 2.029-4.223), pre-existing skin conditions (OR: 2.487, 95% CI: 1.693-3.650), and the use of transparent film dressings (OR: 3.228, 95% CI: 2.086-5.001). Funnel plot and Egger's test showed no significant publication bias.
[CONCLUSIONS] MARSI is prevalent in cancer patients with PICC. Modifiable risk factors should guide prevention strategies, including careful adhesive selection and regular skin assessments to improve patient outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Ultrasound guided transabdominal botulinum toxin injection for refractory overactive bladder treatment.
- Short Nose Lengthening in Primary and Revision Rhinoplasty in Asians.
- Histopathological changes of fibrosis in human extra-ocular muscle caused by botulinum toxin A.
- Corrigendum to "Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study" [Eur. J. Surg. Oncol. 51 (2025) 110548].
- A case report of breast cancer recurrence with cystitis: the impact of immune checkpoint inhibitor therapy on the incidence of cystitis.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.